Yakult Honsha Co Ltd
TSE:2267
Yakult Honsha Co Ltd's latest stock split occurred on Sep 28, 2023
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
Before the split, Yakult Honsha Co Ltd traded at 7561 per share. Afterward, the share price was about 3729.
The adjusted shares began trading on Sep 28, 2023. This was the only stock split in Yakult Honsha Co Ltd's history.
WKSP
NAYA
300803
WKHS
Yakult Honsha Co Ltd
Glance View
Yakult Honsha Co., Ltd., a company rooted in Japanese tradition and scientific innovation, has become a global powerhouse in the probiotics industry. The journey began in 1935 when microbiologist Minoru Shirota pioneered the development of a fermented milk drink containing a unique strain of bacteria, Lactobacillus casei Shirota. This visionary endeavor aimed to improve gut health utilizing the principles of preventive medicine, a novel concept at the time. Yakult's flagship product, a small, iconic bottle of sweet-tasting probiotic milk, swiftly captured the attention and trust of Japanese consumers, setting the company on a trajectory of continuous growth and worldwide expansion. The company leveraged its strong research foundation to consistently innovate its product offerings, ensuring Yakult remained at the forefront of the health and wellness trend. In the modern marketplace, Yakult's operations exemplify a successful case of strategic internationalization. By maintaining a robust distribution network across more than 40 countries, the company effectively taps into varying health consciousness trends across diverse cultures. Revenue is primarily derived from the sales of its probiotic beverages, which are produced through a time-honored fermentation process. Yakult has strengthened its market position through direct sales strategies, including the hallmark “Yakult Ladies,” who personally deliver products to customers, enhancing consumer engagement and fostering brand loyalty. Beyond beverages, Yakult has diversified its portfolio to include cosmetics and pharmaceuticals, though the probiotic drinks remain its core profit engine. This diversification not only draws on the company's microbiological expertise but also mitigates risk by reducing dependency on a single product line.
You don't have any saved screeners yet